Last reviewed: June 25, 2026

Last updated: June 25, 2026

Written by: Jay Hastings, CEO of PlexusDx

Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance.

Medically reviewed by: Jayden Lee, PharmD, EMBA

Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.

This article is part of the PlexusDx Education Hub — science-backed guidance on GLP-1 medications, metabolic health, and precision weight management.

Semaglutide has become a leading medication for weight management, with clinical trials showing average weight loss of 15% over 68 weeks at therapeutic doses. Understanding how dosing works—and how it differs from what you may have read online—helps you make informed decisions about your treatment plan. PlexusDx specializes in personalized semaglutide therapy tailored to your body's unique response patterns.

How Semaglutide Dosing Works for Weight Loss

Semaglutide is a glucagon-like peptide-1 (GLP-1) receptor agonist that signals your brain to reduce hunger and regulate blood sugar. Weight loss doses differ from diabetes doses because the goal is to reach a therapeutic level that balances effectiveness with side effect tolerance. Most patients begin at 0.25 mg injected once weekly, then escalate through four dose increases over 16 weeks, with increases typically happening every 4 weeks.

The standard escalation pathway moves from 0.25 mg to 0.5 mg, then to 1.0 mg, and finally to 2.4 mg weekly. However, not every patient follows this exact timeline—some stabilize at lower doses, while others tolerate and benefit from reaching the full 2.4 mg maintenance dose. Your prescriber monitors your response, side effects, and weight loss progress to determine whether to advance your dose or hold at your current level.

Typical Semaglutide Dose Ranges and Timeline

Starting at the lowest dose (0.25 mg) serves two purposes: it allows your body to adapt to the medication and helps identify how you personally respond to GLP-1 activation. During the first 4 weeks, most patients experience reduced appetite and improved satiety without severe side effects. The gradual escalation reduces nausea, vomiting, and gastrointestinal discomfort that can occur when doses increase too quickly.

Maintenance doses for weight loss typically fall between 1.0 mg and 2.4 mg weekly, depending on individual tolerance and results. Some patients achieve meaningful weight loss at 1.0 mg or 1.7 mg and choose to remain at that level if side effects become bothersome. Others reach 2.4 mg and sustain it long-term as their therapeutic dose. The key principle is finding your personal optimal dose—the point where weight loss benefit aligns with tolerability.

What Influences Your Individual Semaglutide Dose

Your optimal semaglutide dose depends on multiple factors including your baseline weight, metabolic health, genetic predisposition to peptide sensitivity, kidney function, and previous medication responses. PlexusDx uses the Precision Peptide Genetic Test to identify variants in genes like GLP1R (rs6923761) and GIPR (rs1800437) that influence how your body processes and responds to GLP-1 therapies. This genetic insight helps your prescriber predict whether you may achieve results at lower doses or require higher therapeutic levels.

Gastrointestinal tolerance also shapes dosing decisions—some patients experience nausea or constipation that improves with a longer timeline between dose increases, while others progress smoothly. Age, liver function, and concurrent medications can affect how quickly your body metabolizes semaglutide. PlexusDx personalizes your escalation schedule based on these individual factors rather than applying a one-size-fits-all protocol.

Compounded Semaglutide Pricing and Access at PlexusDx

PlexusDx offers compounded semaglutide injections from licensed 503A compounding pharmacies starting at $149 per month. Your dose may need to go up as your treatment progresses, but your price won't—PlexusDx uses flat monthly pricing regardless of whether you're at 0.25 mg or 2.4 mg. This means you can reach your optimal therapeutic dose without facing escalating costs.

No insurance is required, no membership fees apply, and treatment is available across all 50 states. PlexusDx medications are HSA and FSA eligible, and the optional Precision Peptide Genetic Test ($99 add-on after your first month) provides personalized insights into your peptide pathways to guide dose optimization. Your prescriber uses your genetic profile alongside your clinical response to determine the most effective and efficient dosing pathway for your weight loss goals.

How Your Genetics Influence GLP-1 Response

Not everyone responds to GLP-1 medications the same way. Genetic variants — including GIPR rs1800437, GLP1R rs6923761, FTO rs9939609, and MC4R rs17782313 — influence how your body processes these medications, how much weight you lose, and how you tolerate side effects. PlexusDx maps 14 pathways, 49 peptides, and 150+ genetic insights to match each patient to the right medication, dose, and lifestyle protocol for their biology. The PlexusDx Precision Peptide Genetic Test ($99 add-on after your first month of treatment) gives your provider precise insight into your peptide genetic predispositions before the first prescription is written.

Access Personalized GLP-1 Care Through PlexusDx

PlexusDx offers six prescription GLP-1 protocols to all 50 states — no membership, no insurance required, async intake or live consult. The Semaglutide Injection starts at $149/mo. Medications are dispensed from licensed 503A compounding pharmacies following strict quality and safety standards. Add a Precision Peptide Genetic Test for $99 to personalize your protocol from day one.

Frequently Asked Questions

What is the starting dose of semaglutide for weight loss?

The standard starting dose is 0.25 mg injected once weekly. This low initial dose allows your body to adjust to GLP-1 activation and minimizes early side effects like nausea. Your prescriber will increase your dose every 4 weeks if tolerated, with the goal of reaching your personal optimal maintenance dose between 1.0 mg and 2.4 mg.

How long does it take to reach the full 2.4 mg dose?

The standard escalation timeline is 16 weeks—starting at 0.25 mg and increasing every 4 weeks through 0.5 mg, 1.0 mg, 1.7 mg, and finally 2.4 mg. However, some patients may stabilize at lower doses or request a slower escalation if they experience side effects. PlexusDx personalizes your timeline based on your tolerance and response.

Does PlexusDx charge different prices for different semaglutide doses?

No. PlexusDx offers compounded semaglutide injections at a flat monthly price starting at $149/mo, regardless of your dose level. Whether you're taking 0.25 mg or 2.4 mg weekly, your monthly cost remains the same—no flat per-compound pricing increases.

What happens if I experience side effects at a higher dose?

If nausea, vomiting, or other side effects become bothersome, your prescriber can pause your dose escalation or reduce back to your previous dose. Many patients achieve significant weight loss at 1.0 mg or 1.7 mg and maintain that level long-term. PlexusDx supports flexible dosing to maximize both safety and results.

Can genetic testing help determine my ideal semaglutide dose?

Yes. The PlexusDx Precision Peptide Genetic Test identifies variants in GLP1R and GIPR genes that influence your individual response to semaglutide and other GLP-1 therapies. This $99 add-on test (taken after your first month) maps 14 peptide pathways and 150+ genetic insights to guide personalized dose optimization and medication selection.

Related Reading

Pricing and availability current as of June 2026. Compounded GLP-1 medications are not FDA-approved drug products; they are prepared by licensed compounding pharmacies under federal compounding regulations. Compounded semaglutide and tirzepatide are not the same as Wegovy, Ozempic, Zepbound, or Mounjaro. This article is for informational purposes only and does not constitute medical advice. Consult a licensed healthcare provider before starting, stopping, or changing any medication.

Return to the PlexusDx Education Hub for more evidence-based resources on GLP-1 therapy, metabolic health, and personalized weight management.

Medical and Editorial Standards

Medical review process: This article was reviewed for medical accuracy, scientific clarity, evidence alignment, and appropriate discussion of genetics, medications, supplements, biomarkers, and health-related claims.

Sources and evidence: PlexusDx educational content is developed using peer-reviewed research, clinical literature, reputable medical references, and, where applicable, public health or regulatory guidance.

Commercial transparency: PlexusDx offers genetic testing, blood biomarker testing, personalized supplement recommendations, and related precision wellness services. Product mentions are intended to help readers understand available options and should not be interpreted as medical advice.

Important disclaimer: PlexusDx educational content is for informational purposes only and should not be used as a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making decisions about medications, supplements, genetic testing, lab testing, or health-related care.

Real prescribers. Published prices. No surprises.

Licensed providers in all 50 states. Online intake. No insurance, no membership required.

Start My Intake →

~60 seconds · $0 charged until your provider approves